ArticleScientific reports2026
MANet: a multimodal attention convolutional neural network for brain tumor classification.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Classification of brain tumors is a difficult problem in medical imaging analysis. Over the past few years, various deep learning-based techniques have been employed for detecting and classifying tumors from Computed Tomography (CT) and Magnetic Resonance Imaging (MRI). In this paper, a new model referred to as Multimodal Attention based Convolutional Neural Network (MANet) has been proposed for detection and classification of brain tumors. The proposed MANet architecture involves integrating multiple feature sets extracted from MRI images through attention techniques. These include wavelet features, edge features, and texture features. This network is divided into two modules, namely feature extraction and classification. The feature extraction module incorporates three CNN streams assisted by wavelet, edge, and texture attention, respectively. The three streams learn discriminative features from diverse feature sets. The classification module concatenates the features and makes predictions through fully connected layers. The proposed MANet models four classes of brain tumors. These classes include glioma, meningioma, pituitary, and non-tumor classes. The proposed MANet model has been tested using two publicly available datasets. These datasets include Contrast Enhanced Magnetic Resonance Imaging (CT-MRI) and Brain Tumor Magnetic Resonance Imaging (BT-MRI). Comparison has been made between MANet and several other existing methods. Experimental results show that the proposed MANet model outperforms other approaches. Comparisons have been made to many existing state-of-the-art approaches. The experimental findings suggest that the suggested MANet is more effective than other approaches. MANet model reaches the highest level of efficiency with an accuracy of 99.12%, a precision of 99.44%, a recall of 99.35%, a sensitivity of 99.1%, a specificity of 99.6%, and an F1 score of 99.5%. Furthermore, experiments show the efficacy of different attention mechanisms along with suggested multimodal fusion technique. In conclusion, the proposed MANet is very promising as a tool to classify brain tumors.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.